Clinical Trial Update: MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.

View source ↗

Summary

This clinical trial update investigates how the age at first dose influences safety and immunogenicity of the measles component in MMR and MMRV vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Drugs mentioned

• M-M-R II (Measles, Mumps, and Rubella Vaccine)
• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Measles | Status: UNKNOWN